4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001732369-26-000002
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 62,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Seehra Jasbir CHIEF EXECUTIVE OFFICER | 2026-01-07 | Grant or award · Employee Stock Option (right to buy) | +62,500 | 62,500 | D | ||
Loading xslF345X05/form4-01092026_040101.xml…